Impact of time to first antimicrobial dose on length of stay and 30-day hospital readmission in patients with lower limb cellulitis
Jaclyn L Bishop, Mark Jones, James Farquharson, Kathrine Summerhayes, Roxanne Tucker, Mary Smith, Raquel Cowan, N Deborah Friedman, Thomas R Schulz, David CM Kong, Kirsty L Buising
Journal of Global Antimicrobial Resistance | Elsevier | Published : 2021
OBJECTIVES: There have been efforts to promote timely antimicrobial administration for patients with sepsis, but the importance for other infections is uncertain. This study analysed whether time to first antimicrobial dose (TFAD) in patients with lower limb cellulitis influenced outcome measures such as acute length of stay (LOS) in hospital and 30-day hospital readmission rates for cellulitis. METHODS: Medical records of patients admitted with lower limb cellulitis or erysipelas over a 15-month period (1 May 2019 to 30 November 2019 and 1 March 2020 to 31 October 2020) were reviewed. Patients requiring intensive care unit (ICU) admission were excluded. The TFAD was the difference (in minut..View full abstract
Awarded by National Health and Medical Research Council (NHMRC) Centre for Research Excellence (CRE)
This study was directly funded by a research grant from Western Alliance. This work was supported by a National Health and Medical Research Council (NHMRC) Centre for Research Excellence (CRE) grant for the National Centre for Antimicrobial Stewardship [APP1079625] . JLB received an Australian Government Research Training Program Scholarship and a PhD stipend from the National Centre for Antimicrobial Stewardship.